Literature DB >> 31714011

Precipitants of Acute-on-Chronic Liver Failure: An Opportunity for Preventative Measures to Improve Outcomes.

Giuseppe Cullaro1, Rajani Sharma2, Jonel Trebicka3,4,5,6, Andrés Cárdenas7, Elizabeth C Verna2.   

Abstract

Acute-on-chronic liver failure (ACLF) is a feared complication that can develop at any stage of chronic liver disease. The incidence of ACLF is increasing, leading to a significant burden to both the affected individual and health care systems. To date, our understanding of ACLF suggests that it may be initiated by precipitants such as systemic infection, alcohol use, or viral hepatitis. The prevalence of these vary significantly by geography and underlying liver disease, and these precipitants have a varying impact on patient prognosis. Herein, we present a review of our current understanding of the precipitants of ACLF, including gaps in current data and opportunities for meaningful intervention and areas of future research.
Copyright © 2019 by the American Association for the Study of Liver Diseases.

Entities:  

Mesh:

Year:  2020        PMID: 31714011      PMCID: PMC8046290          DOI: 10.1002/lt.25678

Source DB:  PubMed          Journal:  Liver Transpl        ISSN: 1527-6465            Impact factor:   5.799


  76 in total

1.  Liver failure as initial presentation of autoimmune hepatitis: clinical characteristics, predictors of response to steroid therapy, and outcomes.

Authors:  Sumita Verma; Anurag Maheshwari; Paul Thuluvath
Journal:  Hepatology       Date:  2009-04       Impact factor: 17.425

Review 2.  Targeting the gut-liver axis in cirrhosis: antibiotics and non-selective β-blockers.

Authors:  Bjørn S Madsen; Troels Havelund; Aleksander Krag
Journal:  Adv Ther       Date:  2013-07-24       Impact factor: 3.845

3.  Norfloxacin vs ceftriaxone in the prophylaxis of infections in patients with advanced cirrhosis and hemorrhage.

Authors:  Javier Fernández; Luis Ruiz del Arbol; Cristina Gómez; Rosa Durandez; Regina Serradilla; Carlos Guarner; Ramón Planas; Vicente Arroyo; Miguel Navasa
Journal:  Gastroenterology       Date:  2006-10       Impact factor: 22.682

4.  Short-term prognosis in critically ill patients with cirrhosis assessed by prognostic scoring systems.

Authors:  M Wehler; J Kokoska; U Reulbach; E G Hahn; R Strauss
Journal:  Hepatology       Date:  2001-08       Impact factor: 17.425

5.  Effects of Albumin Treatment on Systemic and Portal Hemodynamics and Systemic Inflammation in Patients With Decompensated Cirrhosis.

Authors:  Javier Fernández; Joan Clària; Alex Amorós; Ferrán Aguilar; Miriam Castro; Mireia Casulleras; Juan Acevedo; Marta Duran-Güell; Laura Nuñez; Montserrat Costa; Mireia Torres; Raquel Horrillo; Luis Ruiz-Del-Árbol; Cándido Villanueva; Verónica Prado; Mireya Arteaga; Jonel Trebicka; Paolo Angeli; Manuela Merli; Carlo Alessandria; Niels Kristian Aagaard; German Soriano; François Durand; Alexander Gerbes; Thierry Gustot; Tania M Welzel; Francesco Salerno; Rafael Bañares; Victor Vargas; Agustin Albillos; Aníbal Silva; Manuel Morales-Ruiz; Juan Carlos García-Pagán; Marco Pavesi; Rajiv Jalan; Mauro Bernardi; Richard Moreau; Antonio Páez; Vicente Arroyo
Journal:  Gastroenterology       Date:  2019-03-22       Impact factor: 22.682

Review 6.  The efficacy and safety of nucleos(t)ide analogues in the treatment of HBV-related acute-on-chronic liver failure: a meta-analysis.

Authors:  Shi Yu; He Jianqin; Wu Wei; Huang Jianrong; Yang Yida; Sheng Jifang; Yu Liang; Chen Zhi; Jia Hongyu
Journal:  Ann Hepatol       Date:  2013 May-Jun       Impact factor: 2.400

7.  Acute-on-chronic liver failure is a distinct syndrome that develops in patients with acute decompensation of cirrhosis.

Authors:  Richard Moreau; Rajiv Jalan; Pere Gines; Marco Pavesi; Paolo Angeli; Juan Cordoba; Francois Durand; Thierry Gustot; Faouzi Saliba; Marco Domenicali; Alexander Gerbes; Julia Wendon; Carlo Alessandria; Wim Laleman; Stefan Zeuzem; Jonel Trebicka; Mauro Bernardi; Vicente Arroyo
Journal:  Gastroenterology       Date:  2013-03-06       Impact factor: 22.682

8.  Preemptive-TIPS Improves Outcome in High-Risk Variceal Bleeding: An Observational Study.

Authors:  Virginia Hernández-Gea; Bogdan Procopet; Álvaro Giráldez; Lucio Amitrano; Candid Villanueva; Dominique Thabut; Luis Ibañez-Samaniego; Gilberto Silva-Junior; Javier Martinez; Joan Genescà; Christophe Bureau; Jonel Trebicka; Elba Llop; Wim Laleman; Jose Maria Palazon; Jose Castellote; Susana Rodrigues; Lise L Gluud; Carlos Noronha Ferreira; Rafael Barcelo; Nuria Cañete; Manuel Rodríguez; Arnulf Ferlitsch; Jose Luis Mundi; Henning Gronbaek; Manuel Hernández-Guerra; Romano Sassatelli; Alessandra Dell'Era; Marco Senzolo; Juan G Abraldes; Manuel Romero-Gómez; Alexander Zipprich; Meritxell Casas; Helena Masnou; Massimo Primignani; Aleksander Krag; Frederik Nevens; Jose Luis Calleja; Christian Jansen; Marie Angèle Robic; Irene Conejo; Maria-Vega Catalina; Agustin Albillos; Marika Rudler; Edilmar Alvarado; Maria Anna Guardascione; Marcel Tantau; Jaime Bosch; Ferran Torres; Juan Carlos Garcia-Pagán
Journal:  Hepatology       Date:  2018-12-10       Impact factor: 17.425

9.  New point mutations in surface and core genes of hepatitis B virus associated with acute on chronic liver failure identified by complete genomic sequencing.

Authors:  Hangdi Xu; Mingfei Zhao; Guohua Lou; Min Zheng; Qingyi Cao; Zhi Chen
Journal:  PLoS One       Date:  2015-04-07       Impact factor: 3.240

Review 10.  Hepatic encephalopathy in patients with acute decompensation of cirrhosis and acute-on-chronic liver failure.

Authors:  Manuel Romero-Gómez; Sara Montagnese; Rajiv Jalan
Journal:  J Hepatol       Date:  2014-09-10       Impact factor: 25.083

View more
  4 in total

1.  Improving the Model for End-Stage Liver Disease with sodium by incorporating kidney dysfunction types.

Authors:  Giuseppe Cullaro; Elizabeth C Verna; Charles E McCulloch; Jennifer C Lai
Journal:  Hepatology       Date:  2022-03-31       Impact factor: 17.298

2.  Vulnerability to recurrent episodes of acute decompensation/acute-on-chronic liver failure characterizes those triggered by indeterminate precipitants in patients with liver cirrhosis.

Authors:  Hitomi Hoshi; Po-Sung Chu; Aya Yoshida; Nobuhito Taniki; Rei Morikawa; Karin Yamataka; Fumie Noguchi; Ryosuke Kasuga; Takaya Tabuchi; Hirotoshi Ebinuma; Hidetsugu Saito; Takanori Kanai; Nobuhiro Nakamoto
Journal:  PLoS One       Date:  2021-04-13       Impact factor: 3.240

Review 3.  Animal models applied to acute-on-chronic liver failure: Are new models required to understand the human condition?

Authors:  Jaciara Fernanda Gomes Gama; Liana Monteiro da Fonseca Cardoso; Jussara Machado Lagrota-Candido; Luiz Anastacio Alves
Journal:  World J Clin Cases       Date:  2022-03-26       Impact factor: 1.337

4.  Dynamic Prognostication in Transplant Candidates with Acute-on-Chronic Liver Failure.

Authors:  Cheng-Yueh Lu; Chi-Ling Chen; Cheng-Maw Ho; Chih-Yang Hsiao; Yao-Ming Wu; Ming-Chih Ho; Po-Huang Lee; Rey-Heng Hu
Journal:  J Pers Med       Date:  2020-11-15
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.